Longstanding insulin dependent diabetics may not require insulin after the introduction of GLP-1 analogues
Glucagon like peptide (GLP-1) analogues are a relatively novel medication developed primarily for the treatment of type 2 diabetes since 2005. Although GLP-1 analogues have been shown to be more effective in the first few years of diagnosis in type 2 diabetes, we report a case of a patient with long...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2015-03-01
|
| Series: | JRSM Cardiovascular Disease |
| Online Access: | https://doi.org/10.1177/2048004015576008 |